AML TAMs have been characterized as CD45+Lys6G–CD11b+ macrophages and are called AML-associated macrophages (AAMs) (28), whereas tissue-resident BMMs express CD45+GR1–F4/80+CD115int (Supplemental Figure 4A and 38). This evidence concerns the gene PTPRC and acute myeloid leukemia.